................................................................................................................. counter
!!! W E L C O M E !!!
In INDIA, people generally relate to stock market as “EASY MONEY” or “SATTA BAZAAR”. For them it’s purely a GAME or matter of sheer LUCK and nothing more than that. But seldom do they know, by following certain PRINCIPLES and taking INFORMED decision, this same platform has the power to take them from rags to riches. No doubt, it has a certain amount of RISK attached to it. But every business or investment has it. What more, the Finance Ministry has already made the long term capital gain as TAX FREE whereas the short term capital gain is taxed at merely 10%. On the economic front, India’s GDP is growing and is expected to grow at scorching pace of more than 8%. Unfortunately, even today our market is being ruled and dominated by FIRANGI’s money. But I can see, the day is not far when our general PUBLIC will change its perception and start putting MOST of their savings in equities as an ** Investment **.
Remember, "K N O W L E D G E" and "P A T I E N C E" are the key to success.
Page copy protected against web site content infringement by Copyscape
AddThis Social Bookmark Button Add to Technorati Favorites Join My Community at MyBloglog! ...<< Top Blogs >>
SAARTHI

Sensex (LIVE- Intraday)

Sensex (LIVE- Intraday)

Wednesday, June 1, 2005

STOCK WATCH

Hazoor Media (Code No: 532467) (Rs.10.35) has entered into a joint venture project with Omkar Petrochemicals Limited to jointly set up project with an installed capacity of 30K litres per day for manufacturing Ethanol an Energy Fuel. It has also made its foray into the power sector to set up 10 MW co-generation power project for generation and distribution of grid quality power from biomass resources using steam turbine technology. Besides, it has huge real estate of 90,000 sq. mtrs. Being a zero debt company with a book value of Rs.19, its share price can easily rise 50% from the current level. At the same time, equity dilution cannot be ruled out in future.

Electrotherm India (Code No: 526608) (Rs.85.85) manufactures induction melting furnaces, induction heating & hardening equipment, single electrode DC arc furnaces, secondary metallurgical equipments etc for the steel industry and is a major player in the domestic and export markets. It is setting up a 70,000 TPA cast iron manufacturing facility in the Kutch District of Gujarat, which will boost its topline significantly. In future, the company also intends to go for backward and forward integration to become an integrated player. For FY05, it may report an EPS of Rs.20. Investors can accumulate it at declines for the long term as there is the possibility of equity dilution in the near future. The scrip is now available in demat mode.

GMM Pfaudler (Code No:505255) (Rs.357) is the largest domestic manufacturer of Glass lined reactors and its products line includes Wiped Film Evaporators, Agitated Nutche Filters and High efficiency Mixing Systems. It has chalked out aggressive plans to tap the growing market of pharmaceutical equipment in the post-patent regime by introducing products that are compliant with international standards. In FY05, its OPM has improved substantially to 15% from 8% last year. It reported an EPs of Rs.25, which may shoot up to Rs.35 in FY06 and its share price can cross Rs.500 in the medium term

Bhagyanagar Metals (Code No: 512296) (Rs.26) intends to restructure its businesses Telecom, Metals, Investments and Infrastructure. It may continue as a Metals & Investment Company and demerge the company's telecom business to Bhagyanagar Telecom Limited, Infrastructure business to Bhagyanagar Infrastructure Limited. This will lead to a re-rating of the scrip in future, as each company will concentrate on its core strength. For FY05, it reported an EPS of Rs.8.5 (FV of Rs.2) as other income constitutes 40% of its bottomline.

Hind Rectifiers (Code No: 504036) (Rs.328.40) produces electrostatic precipitators, transformers, reactors, mobile submarine battery chargers, constant current regulators for the Defence sector and rectifier systems, pulse power supply systems, regulators, power diodes, thyristors, auxiliary converters & inverters, and trackside DC substation equipment for others. The company has a healthy order book position and is expected to perform far better in FY06. It may report an EPS of Rs.33 and Rs.42 for FY05 and FY06 respectively. With a very small equity of Rs.1 cr. and reserves of around Rs.8 cr., there is possibility of a bonus issue in the near future. A strong buy.

Recently Alchemist Ltd (Code No: 526707) (Rs.108.35) bought 60 per cent stake in Valiant Healthcare Limited, a Delhi based pharma company for Rs.4.5 cr. as a part of its growth strategy to focus on Healthcare and Agri business. Alchemist is setting up a R&D Centre to offer drug development support services (DDSS) to global pharmaceutical companies and is also planning to focus on Clinical Research Operations through its presence in hospital, clinical and pathological lab segment. For FY05 ending 30th June 2005, it may report an EPS of Rs.25 on its current equity of Rs.5.50 cr. Scrip has the potential to cross Rs.150 in the next 3 months.

Friday, May 27, 2005

Dhanuka Pesticides - Rs.104.00

Incorporated in 1985 and promoted by the Dhanuka Group, Dhanuka Pesticides Ltd (DPL) is engaged in the manufacture of various technical-grade pesticides, which include insecticides and weedicides and has emerged as one of the top pesticides formulators and marketing organisation in India. The Dhanuka Group is a well established manufacturer / formulator of a wide range of popular pesticides; in ECS, Granules, Wettables & Dust Formulations of Insecticides, Fungicides, Weedicides, PGR, Growth Stimulant and Wetting Agents. Whereas DPL’s product profile includes Methomyl 12.5; L, Ethofenprox 10%; Validamycin 3%; L, Kasugamycin 3%; L, Cypermethrin 10%; EC, Cypermethrin 25%; Fenvalerate 20%; Cartap hydrochloride 50%; Methomyl 40%; and Cartap hydrochloride 4% G.

DPL's production facilities are located in Gurgaon district of Haryana, It has a technical tie-up with Du Pont of USA for the formulations of pesticides using as methomyl raw material. Apart from this it has entered into a series of technical tie-up agreements with a number of Japanese multinationals like Takeda Chemicals Industries Ltd for Cartap Hydrochloride and Validamycin, Mitsui Chemicals Inc for Etofenprox, Hokko Chemicals Ind. Co. Ltd. for Kasugamycin etc. Last year, DPL launched a new insecticide under the brand name ‘DHAWA’ (Indoxacarb 14.5% SC) which got a huge response from the cotton dominant Indian market. It is an eco-friendly and safe molecule with widespread application to control the insects in cotton especially for American bollworm, a major cotton insect. The company is also launching a new, safe and eco-friendly herbicide under the brand name 'QURIN' (Chlorimuron Ethyl 25% WP), in a marketing tie-up with E.I.Du-Pont India. The Dhanuka group has a huge network of distributors, preferred dealers and retailers (over 8000) supported by its branch offices in almost every state. Moreover for the future growth DPL, it is strengthening in house R & D for process improvement and new molecules, obtain safer and eco-friendly products through tie-ups, extend and implement the cause of right and judicious use of pesticides and consequently sustained growth of the group. Besides, an export remains a huge potential market.
India primarily being an agriculture country, the government has put special thrust on agricultural development for higher GDP growth. And with the Meteorological Department predicting good monsoon this season also, it will be a bumper year for DPL. With an increasing trend in the use of pesticides and other crop protection methods by Indian farmers, DPL has a very bright future ahead. For the nine months ending 31st Dec 2004, its Net Sales jumped around 120% to Rs.49 cr. and NP tripled to Rs.3 cr. For the full year, it is expected to report an EPS of Rs.20, which may shoot up to Rs.24 in FY06. Long term investors can accumulate this scrip at sharp declines on expectation of 100% returns in 15~18 months.

Thursday, May 26, 2005

Kilburn Engineering - Rs.64.00

Incorporated in 1987, Kilburn Engineering Ltd. (KIL) is an associate company of Williamson Magor Ltd., which is one of the 20 large industrial groups operating in India. The company specialises in process design, engineering, manufacture, installation and commissioning of turnkey plants/systems for petrochemicals, chemicals, fertilizers, refineries, oil & gas, food processing, etc. It is also engaged in designing, manufacturing, marketing, field erection and commissioning of industrial drying system, oil field and air handling equipment. KIL is well-known in the field of industrial drying, its core strength being ‘Heat and Mass Transfer Systems’. Besides, it has expertise in chemical engineering and chemical treatment process and also deals in fabrication equipments like heat exchangers, evaporators, reactors etc.

KIL has a modern and well-equipped workshop equipped with machining, fabrication, testing and allied facilities and has a technical collaboration with Nara Machinery Co of Japan and Carrier Vibrating Equipment of USA. It has been awarded ISO-9001: 2000 Quality System Certification by M/S. Det Norske Veritas (DNV) of the Netherlands and has been accredited by the RVA. The company exports equipments to over 25 countries worldwide including Japan, Italy, USA, France, China, Taiwan and Malaysia etc. In the domestic market GAIL, HLL, IPCL, Gujarat Alkalies, GNFC, L&T, DCM Shriram, Nirma, HPCL are among its reputed clients. This year, it started supplying new Phase V Tea Dryer to Kenya Tea Development Authority. KIL has also designed and developed equipment for the rice mill industry to diversify its product range. It has also successfully negotiated to export Paddle dryers to M/s. Komline Sanderson, USA. Few months back, it supplied dryers to Ivory Coast in Africa for processing of desiccated coconut. It is also focusing on the food processing industry, which has a huge growth potential. KIL is putting more thrust on exports and intends to take it to 40% of total sales from the current 25%. In short, it has a very healthy order book position, which includes repeat orders from world-class companies.

Under the rehabilitation scheme sanctioned by the BIFR, KIL has got various fiscal reliefs, benefits and concessions from the lenders/bankers due to which it turned around last fiscal ending Sept 04. In February 2004, it sold off a property in Baroda for a one-time settlement with financial institutions and paid off Rs.16 cr. It has brought down its debt from Rs.87 cr. to Rs.24 cr. and expects to wipe out all its carry forward losses by 2006~07. Recently, the company issued Right shares to raise funds for its working capital requirement. In future, it may also re-locate its Mumbai factory in Bhandup, and sell this prime property and improve its operating efficiency using the funds generated. For the six months ending March 2005, its turnover has more than doubled to Rs.25 cr. and NP stood at Rs.3.75 cr. compared to Net Loss of Rs.5.70 cr. For full FY05, it may report sales of Rs.55 cr. and NP of Rs.8 cr. resulting in an EPS of Rs.12 on it current equity of Rs.6.75 cr. Diluted EPS on its expanded equity may amount to Rs.8. For FY06, it can post an EPS of Rs.14 on the expanded equity. For investors, it is a very good bet from the engineering sector and they can expect a price target of Rs.150 in 15 months.

Wednesday, May 25, 2005

STOCK WATCH

Laffans Petro (Code No: 524522) (Rs.24) is engaged in manufacturing ethylene oxide derivatives such as Ethoxylates, Glycol Ethers, Acetates, Triethonal-amine, and Brake fluids. Due to higher demand and better price realisation on its products, Laffans Petrochemicals has improved its operating efficiency and is expected to perform much better in coming quarters. For FY05 ending Sept 2005, it may report an EPS of more than Rs.5 and the share price can appreciate by 50% in the next 12 months. A good medium term bet. Due to the uptrend in the Steel sector and strong demand for their products the refractory industry is enjoying the best of times. Raasi Refractories (Code No: 502271) (Rs.29) is a Hyderabad based small player that has posted a good turnaround. It also manufactures high temperature shuttle kiln, heavy-duty top and bottom pressing hydraulic presses, PLC controlled heavy-duty mechanical presses, high intensity mixing equipment and latest lab equipment such as Hot MOR testing machine and photometer. For the nine months ending 31st Dec’ 04, its topline tripled to Rs.16 cr. and it reported a NP of Rs.1.30 cr. against a Net loss of 1.20 cr. in the corresponding previous period. It is expected to report an EPS of Rs.5 for FY05, which may shoot upto Rs.7 for FY06.

The cool off in metal prices will have a positive impact on Ashok Leyland (Code No: 500477) (Rs.24) to a certain extent. It reported an excellent performance for the March 2005 quarter with Sales jumping 30% to Rs.1460 cr. and NP zooming 65% to Rs.143 cr. including Rs.33 cr. as other income. It posted an EPS of Rs.2.30 for FY05 and may report Rs.2.60 for FY06. The outlook for the commercial vehicle segment is very robust and may continue to grow in double digits. The share price has the potential to hit Rs.35 in 12~15 months

Since the last few weeks, companies engaged in agro and food products are attracting market attention with rising sharply on the bourses. At this stage, one can take some exposure in Jhunjhunwala Vanaspati (Code No: 519248) (Rs.26.50) and keep accumulating it at declines. It reported pretty decent numbers for the March 2005 quarter and ended FY05 with an EPS of Rs.8.5. In the current small cap bull run, this scrip can cross Rs.50.

In the Chemicals sector, National Peroxide (Code No: 500298) (Rs.4479.85) this Bombay Dyeing Group Company was very popular one time. It is engaged in manufacturing of Hydrogen Peroxide is trading reasonably cheap. It has a very small equity of Rs.2.30 cr. and very low floating stock since its face value is Rs.100 and the promoters hold 65%. Due to increased production and higher price realization, it reported fabulous numbers for FY05.Sales increased 30% to Rs.75 cr. and NP doubled to Rs.14.30 cr. reporting an EPS of Rs.620. For FY06 it can post an EPS of Rs.720

Lot of positive developments is taking place in Tinplate Company (Code No: 504966) (Rs.55.65). The company is already implementing a phase-wise expansion programme of its existing unit which will take its tinplate making capacity to around 4,00,000 TPA in the next few years. It is also planning to set up a greenfield project with state-of-the-art tinning line in Jamshedpur at an investment of Rs.100 cr. The company has also started offering cost effective packaging solutions to the end-user industry. Besides, it is putting more thrust on exports and intends to become a dominant player in South East and West Asian markets. For the March 2005 quarter it reported stunning numbers posting a quarterly EPS of Rs.5. For FY06, it can report an EPS of Rs.14. A strong long term buys.

Friday, May 20, 2005

Syncom Formulations - Rs.95.00

Incorporated in 1988, Syncom Formulations (India) Ltd (SFL) is promoted by Kedarmal Bankda, Ajay Kumar Bankda and Vijay Kumar Bankda. The company is mainly engaged in pharmaceutical formulations. Its state-of- the-art manufacturing facilities located at Pithampur in Dhar district of Madhya Pradesh and Palghar in Thane near Mumbai. It’s an ISO 9001:2000 certified company. Keeping in view the shifting consumer preferences for the use of herbal products, the company has initiated steps to aggressively manufacture and market of herbal products. Some of the products already marketed are Edicare, Attom Megacaps, Ecziguard, Yes Antacid salt etc. For future growth, the company is putting more thrust on exports and has successfully established its footprint in more than 15 countries of Africa, Latin America, C.I.S. and Asia. To expand its market reach, SFL is in the process of appointing a distributors in Kenya, Tanzania, Philippines, Russia, Ukraine, Moldova and the Domino Republic.

Interestingly, SFL has more than 250 products to offer in ethical, generics, OTC and the herbal range. It is planning to increase its product offering upto 500 products within the next 2/3 years and has earmarked significant resources for product registration process in various overseas markets. Additionally, it has a basket of 20 well-tested and proven herbal products and has high level plans for marketing. SFL is planning an aggressive entry into branded herbal market of South Africa and Europe for which it has already appointed a distributor in South Africa and negotiations are on with an international player to market its herbal range in Europe. It plans to capture a significant market share in these markets through joint promotional activities. SFL has also entered into long-term sales contracts with its distributors in Vietnam, Cambodia, Philippines, and Nigeria.

Besides, the company is negotiating with a Latin American company for contract manufacturing of its brands at its WH0-GMP certified facility. It is also planning to offer comprehensive contract manufacturing services including pilot plant, technical services, quality control and regulatory services for both domestic as well as foreign companies. To take advantage of the burgeoning contract manufacturing, SFL plans to make substantial investment in a new export oriented unit in a special economic zone (SEZ) at Pithampur near Indore. Apart from its contract manufacturing focus, the company has prepared a blueprint to tap the virgin markets of West Africa by increased focus on licensing arrangements with various international players.

To fund all this expansion and growth plans, the promoters are infusing fresh capital regularly as and when required. Earlier in March’05, they made preferential issue of 2.65 lakh shares to themselves at Rs.90 and are now planning to issue 2.78 lakh shares at Rs.84. For FY05, its net sales increased by 21% to Rs.53.50 cr. whereas NP zoomed 135% to Rs.7.10 cr. leading to an EPS of Rs.13. For FY06, we expect it to report Net Sales of Rs.65 cr. and NP of Rs.10 cr., which means an EPS of Rs.18. Investors are recommended to buy this scrip at dips with a price target of Rs.150 in 8~12 months. Long -term investors can even expect a price of Rs.250 in 24 months.